Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes

https://doi.org/10.1016/0022-2828(92)91100-JGet rights and content

Abstract

Isolated adult rat myocytes were subjected to 180 min of metabolic inhibition or incubated in ischaemic pellets, in the presence and absence of 10 μm okadaic acid (OA) or calyculin A (CL-A). Contracture and viability was determined by light microscopic analysis of trypan blue-stained preparations and ATP levels by HPLC. Osmotic fragility was assessed by brief hypotonic swelling of cells in 170 or 85 mOsm media prior to determination of viability. Neither drug significantly affected the relatively rapid rates of contracture of myocytes during metabolic inhibition, and both afforded significant protection from development of trypan blue permeability and osmotic fragility. Both OA and CL-A significantly accelerated the rates of contracture and ATP depletion of myocytes during ischaemic incubations. Despite an enhanced rate of ATP depletion, which would be expected to accelerate development of injury, neither drug accelerated development of loss of viability or development of osmotic fragility as measured by 170 mOsm swelling. Mathematical compensation for different rates of ATP depletion confirmed that a protective effect of the drugs, during ischaemic incubation, was masked by their enhancement of the rate of injury, following swelling at 170 mOsm. When the effects of CL-A on ischaemic cells were examined at 85 mOsm, a more stringent test for osmotic fragility, protection was found without compensation for differing rates of ATP depletion. A dose/response curve for CL-A showed some effect at 100 nm and a nearly full effect during metabolic inhibition at 1 μm concentrations. It is concluded that protein phosphatase inhibitors reduce the rates of development of osmotic fragility of metabolically inhibited cells and reduces the rate of injury relative to the rate of ATP depletion of ischaemic cardiomyocytes. Phosphorylation mechanisms may be important to development of irreversible myocardial cell injury.

References (38)

  • C.E. Ganote et al.

    Protection from irreversible hypoxic injury by potassium cardioplegia and hypothermia: Effects on contracture, morphology and O2-enzyme release

    J Mol Cell Cardiol

    (1982)
  • Q. Li et al.

    Energy depletion-repletion and calcium transients in single cardiomyocytes

    Am J Physiol

    (1989)
  • B. Siegmund et al.

    Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes

    Am J Physiol

    (1991)
  • C. Steenbergen et al.

    Elevation in cytosolic free calcium concentration early in myocardial ischaemia in perfused rat heart

    Circ Res

    (1987)
  • C. Steenbergen et al.

    Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischaemic injury in perfused rat heart

    Circ Res

    (1990)
  • S.C. Armstrong et al.

    Effects of the phospholipase inhibitor mepacrine on irreversible injury in ischaemic and metabolically inhibited adult isolated myocytes

    Am J Pathol

    (1991)
  • P Cohen

    The structure and regulation of protein phosphatases

    Annu Rev Biochem

    (1989)
  • J. Hescheler et al.

    Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes

    Pflügers Arch

    (1988)
  • H. Ishihara et al.

    Calcium-independent activation of contractile appartus in smooth muscle by calyculin-A

    J Pharmacol Exp Ther

    (1989)
  • Cited by (46)

    • Connexin channel and its role in diabetic retinopathy

      2017, Progress in Retinal and Eye Research
      Citation Excerpt :

      Work by Kondo et al. demonstrated removal of extracellular [Ca2+] and metabolic inhibition can activate non-selective electrical current, which may impact ionic fluxes, and promote arrhythmias and myocardial infarction (Kondo et al., 2000). The activity of phosphatases and protein kinases is elevated whereas Cx43 is dephosphorylated during myocardial ischemia (Armstrong and Ganote, 1992; Beardslee et al., 2000). In other studies, mitogen-activated protein kinases (MAPK), PKC and PTK signaling pathways are reported to be involved in cardiac protection during ischemia (Weinbrenner et al., 1998).

    • Zinc plays a critical role in the cardioprotective effect of postconditioning by enhancing the activation of the RISK pathway in rat hearts

      2014, Journal of Molecular and Cellular Cardiology
      Citation Excerpt :

      In support, PP2A inhibition with fostriecin has been demonstrated to protect rabbit hearts from ischemia/reperfusion injury [38]. Similarly, inhibition of protein phosphatases with okadaic acid or calyculin A could protect cardiomyocytes from ischemic injury [39]. However, since these chemicals may also act on other subtypes of Ser/Thr protein phosphatases, more studies are required to determine if other protein phosphatases are also involved in the activation of the RISK pathway by ischemic postconditioning.

    • Biological role of connexin intercellular channels and hemichannels

      2012, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      Kondo et al. [59] show electrophysiologically that removal of extracellular [Ca2+] and metabolic inhibition allows activation of non-selective current which may have a role in alteration of ionic fluxes thereby promoting arrhythmias and myocardial infarction. During myocardial ischemia, Cx43 is dephosphorylated and activity of several protein kinases and phosphatases gets affected [60–62]. The initiation of ischemia which accounts for the first few minutes does not affect the partially phosphorylated status of the physiological sarcolemmal Cx43 [63].

    View all citing articles on Scopus
    View full text